crystalline polymorph, process for preparing a polymorph, pharmaceutical composition, purified form of the polymorph, use of a polymorph, process for preparing a compound, and, compound.

摘要

Polymorphs of 3-chloro-4[(2R)-2-(4-chlorophenyl)-4-[(1R)-1-(4-cyanophenyl)ethyl]-1-piperazinyl]-benzonitrile are disclosed, as well as pharmaceutical compositions comprising said polymorphs, methods of using the polymorphs, and a process for preparing them.